Literature DB >> 31076492

Measles in pregnancy.

Jassimran Bansal1, Aisha Hameed2.   

Abstract

Measles is becoming more prevalent; it can be difficult to diagnose, with severe complications in pregnancy. We report a case of measles in a 27-year-old, parainfluenza virus type 2-infected woman who was 32 weeks pregnant. She presented with fever, tachycardia, sore throat and a pruritic rash. She never had the measles, mumps, rubella vaccine. Serology showed raised inflammatory markers with lymphopoenia. Throat swab showed parainfluenza virus. Chest radiography was normal. Despite appropriate antimicrobial therapy, she developed worsening respiratory failure requiring premature delivery via caesarean section.Postoperatively, she was transferred to a tertiary centre for extracorporeal membrane oxygenation. She was decannulated and made a full recovery. Meanwhile, her husband was diagnosed with measles. She was then tested and measles was confirmed. The baby did not develop congenital measles.This case emphasises the importance of vaccine histories at booking of pregnancy and early multidisciplinary team input to facilitate delivery in rapidly deteriorating pregnant women. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  TB and other respiratory infections; infections; obstetrics and gynaecology; pregnancy; vaccination/immunisation

Mesh:

Substances:

Year:  2019        PMID: 31076492      PMCID: PMC6536234          DOI: 10.1136/bcr-2018-228781

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Causes and consequences of fetal acidosis.

Authors:  C S Bobrow; P W Soothill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  Complications of measles during pregnancy.

Authors:  R L Atmar; J A Englund; H Hammill
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Measles in pregnancy: maternal morbidity and perinatal outcome.

Authors:  M E Ali; H M Albar
Journal:  Int J Gynaecol Obstet       Date:  1997-11       Impact factor: 3.561

4.  A suspected viral rash in pregnancy.

Authors:  Jack Carruthers; Alison Holmes; Azeem Majeed
Journal:  BMJ       Date:  2017-03-03

5.  Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study.

Authors:  M Siegel
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

Review 6.  Measles, mumps, and rubella.

Authors:  Sarah J White; Kristi L Boldt; Sara J Holditch; Gregory A Poland; Robert M Jacobson
Journal:  Clin Obstet Gynecol       Date:  2012-06       Impact factor: 2.190

7.  Measles infection in pregnancy.

Authors:  Makiko Egashira Chiba; Masatoshi Saito; Nobuaki Suzuki; Yoshinobu Honda; Nobuo Yaegashi
Journal:  J Infect       Date:  2003-07       Impact factor: 6.072

Review 8.  The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review.

Authors:  G Manikkavasagan; M Ramsay
Journal:  J Obstet Gynaecol       Date:  2009-10       Impact factor: 1.246

9.  Increased perinatal mortality among children of mothers exposed to measles during pregnancy.

Authors:  P Aaby; J Bukh; I M Lisse; E Seim; M C de Silva
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

10.  Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult Patients.

Authors:  Cédric Rafat; Kada Klouche; Jean-Damien Ricard; Jonathan Messika; Antoine Roch; Sonia Machado; Romain Sonneville; Olivier Guisset; Wilfried Pujol; Claude Guérin; Jean-Louis Teboul; Natacha Mrozek; Michaël Darmon; Frank Chemouni; Matthieu Schmidt; Emmanuelle Mercier; Didier Dreyfuss; Stéphane Gaudry
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

View more
  1 in total

Review 1.  Innate Immune Responses to Acute Viral Infection During Pregnancy.

Authors:  Emily F Cornish; Iva Filipovic; Fredrika Åsenius; David J Williams; Thomas McDonnell
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.